Xiaoren Zhang

3.3k total citations · 1 hit paper
49 papers, 1.8k citations indexed

About

Xiaoren Zhang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaoren Zhang has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Immunology and 16 papers in Cancer Research. Recurrent topics in Xiaoren Zhang's work include NF-κB Signaling Pathways (8 papers), Cancer-related molecular mechanisms research (7 papers) and Advanced Chemical Physics Studies (6 papers). Xiaoren Zhang is often cited by papers focused on NF-κB Signaling Pathways (8 papers), Cancer-related molecular mechanisms research (7 papers) and Advanced Chemical Physics Studies (6 papers). Xiaoren Zhang collaborates with scholars based in China, United States and United Kingdom. Xiaoren Zhang's co-authors include Qiang You, Yingchang Li, Ting Zhao, Zhongping Su, Yufang Shi, Jun Chen, Zhanliang Tao, Xiaodi Ren, Donghui Zhang and Shibing Zheng and has published in prestigious journals such as Nature Communications, The Journal of Chemical Physics and Immunity.

In The Last Decade

Xiaoren Zhang

48 papers receiving 1.8k citations

Hit Papers

Chitinase-3 like-protein-... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoren Zhang China 21 802 434 303 264 214 49 1.8k
Hyun-Jung Choi South Korea 20 757 0.9× 428 1.0× 215 0.7× 289 1.1× 251 1.2× 46 2.6k
Mi Zhou United States 28 1.3k 1.6× 261 0.6× 373 1.2× 296 1.1× 85 0.4× 83 2.3k
Roberta Di Pietro Italy 24 985 1.2× 387 0.9× 274 0.9× 289 1.1× 91 0.4× 101 1.9k
Cheng Cheng China 22 775 1.0× 239 0.6× 173 0.6× 222 0.8× 66 0.3× 75 1.8k
Noriko Ito Japan 26 433 0.5× 218 0.5× 364 1.2× 317 1.2× 341 1.6× 74 1.7k
Rongrong Wu China 28 1.1k 1.4× 189 0.4× 356 1.2× 224 0.8× 83 0.4× 106 2.5k
Dongzhou Liu China 21 430 0.5× 631 1.5× 100 0.3× 147 0.6× 395 1.8× 79 1.7k
Xiaozhong Wang China 26 1.6k 2.0× 213 0.5× 711 2.3× 290 1.1× 57 0.3× 91 2.8k
Xudong Wang China 33 1.4k 1.7× 425 1.0× 737 2.4× 487 1.8× 491 2.3× 99 2.9k
Zongyou Chen China 27 991 1.2× 384 0.9× 684 2.3× 438 1.7× 94 0.4× 97 2.1k

Countries citing papers authored by Xiaoren Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaoren Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoren Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoren Zhang more than expected).

Fields of papers citing papers by Xiaoren Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoren Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoren Zhang. The network helps show where Xiaoren Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoren Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoren Zhang. A scholar is included among the top collaborators of Xiaoren Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoren Zhang. Xiaoren Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Weifeng, Yuhang Jiang, Jun Zeng, et al.. (2025). FDX1 promotes elesclomol-induced PANoptosis in diffuse large B-cell lymphoma via activating IRF3/IFN-β signaling. Oncogene. 44(27). 2303–2314.
2.
Si, Ke, Zehang Jiang, Zhi‐Yong Wu, et al.. (2025). A novel lncRNA-mediated signaling axis governs cancer stemness and splicing reprogramming in hepatocellular carcinoma with therapeutic potential. Journal of Experimental & Clinical Cancer Research. 44(1). 287–287. 1 indexed citations
3.
Liu, Yun, Li Zhang, Guiqin Xu, et al.. (2024). Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy. Science Advances. 10(37). eadi7764–eadi7764. 7 indexed citations
4.
Qian, Guojun, Wenxia Jiang, Hongwei Fang, et al.. (2023). B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3. Cellular and Molecular Immunology. 20(11). 1313–1327. 15 indexed citations
5.
Chen, Jun, et al.. (2023). Feshbach resonances in the F + CHD 3 → HF + CD 3 reaction. Chemical Science. 14(29). 7973–7979. 7 indexed citations
6.
Zhang, Li, Kun Jiao, Yun Liu, et al.. (2023). UBXN9 inhibits the RNA exosome function to promote T cell control of liver tumorigenesis. Hepatology. 80(5). 1041–1057. 7 indexed citations
7.
Zhao, Ting, Jianming Zeng, Yujie Xu, et al.. (2022). Chitinase-3 like-protein-1 promotes glioma progression via the NF-κB signaling pathway and tumor microenvironment reprogramming. Theranostics. 12(16). 6989–7008. 46 indexed citations
8.
Yang, Zhaojuan, Guiqin Xu, Boshi Wang, et al.. (2021). USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nature Communications. 12(1). 4852–4852. 35 indexed citations
9.
Hu, Yiming, Haohao Zhang, Ningxia Xie, et al.. (2021). Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1. Cell Death and Differentiation. 29(6). 1176–1186. 16 indexed citations
10.
Wang, Jingyao, Dandan Liu, Ningxia Xie, et al.. (2021). A Robust Panel Based on Mitochondrial Localized Proteins for Prognostic Prediction of Lung Adenocarcinoma. Oxidative Medicine and Cellular Longevity. 2021(1). 7569168–7569168. 2 indexed citations
11.
Zhang, Junwei, Ting Zhao, Yu-Jie Xu, et al.. (2021). Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma. Frontiers in Immunology. 12. 782551–782551. 10 indexed citations
12.
Liu, Zhi, Haohao Zhang, Yiming Hu, et al.. (2020). Critical role of histone H3 lysine 27 demethylase Kdm6b in the homeostasis and function of medullary thymic epithelial cells. Cell Death and Differentiation. 27(10). 2843–2855. 5 indexed citations
13.
Zhou, Yonggang, Binqing Fu, Xiuxiu Xu, et al.. (2020). PBX1 expression in uterine natural killer cells drives fetal growth. Science Translational Medicine. 12(537). 62 indexed citations
14.
Zhao, Ting, Zhongping Su, Yingchang Li, Xiaoren Zhang, & Qiang You. (2020). Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduction and Targeted Therapy. 5(1). 201–201. 326 indexed citations breakdown →
15.
Zhang, Xiaoren, et al.. (2020). Feshbach resonances in the F + H2O → HF + OH reaction. Nature Communications. 11(1). 223–223. 26 indexed citations
16.
Huang, Chao, Zhe Zhang, Lihan Chen, et al.. (2018). Acetylation within the N- and C-Terminal Domains of Src Regulates Distinct Roles of STAT3-Mediated Tumorigenesis. Cancer Research. 78(11). 2825–2838. 16 indexed citations
17.
Zhang, Li, Yun Liu, Boshi Wang, et al.. (2018). POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity. Nature Communications. 9(1). 4225–4225. 33 indexed citations
18.
Chen, Xi, Haohao Zhang, Yiming Hu, et al.. (2018). Bcl-3 promotes proliferation and chemosensitivity in BL1 subtype of TNBC cells. Acta Biochimica et Biophysica Sinica. 50(11). 1141–1149. 5 indexed citations
19.
Chen, Pengfei, Jun Zhang, Yu Zhan, et al.. (2013). Established Thymic Epithelial Progenitor/Stem Cell-Like Cell Lines Differentiate into Mature Thymic Epithelial Cells and Support T Cell Development. PLoS ONE. 8(9). e75222–e75222. 1 indexed citations
20.
Wang, Ruoxiang, Liying Zhang, Xiaoren Zhang, et al.. (2001). Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-κB Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-α During T Cell Activation. The Journal of Immunology. 166(3). 1983–1990. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026